Tools chosen: kalshi_direct kalshi_related fred code_execution claude_news polymarket_related gdelt_news

Sub-questions (Fermi decomposition)

Planner reasoning

This is a Kalshi economics market resolving on FRED series FGEXPND (federal government current expenditures, SAAR): needs any quarter through Q4 2028 to print at least $250B below the Q4 2024 level. The key empirical inputs are the Q4 2024 baseline level, the historical frequency of nominal quarterly declines of that magnitude, and the current fiscal/policy trajectory (DOGE cuts, appropriations, mandatory spending growth, interest costs). Market price is the primary anchor.

# Current state FGEXPND (federal current expenditures, SAAR) must fall ≥$250B below the Q4 2024 level ($7,247.7B) in ANY quarter through Q4 2028 for this to resolve Yes — i.e., must hit ≤$6,997.7B. Every quarter since Q4 2024 has instead been HIGHER, with Q2 2026 (latest, $7,763.7B) up $516B from the baseline. Kalshi prices this at 4.1% and falling. # Timeline of key events - 2024-10-01 (baseline): FGEXPND = $7,247.662B SAAR (Q4 2024). [FRED, confirmed] - 2025-01 to 2025-10: FGEXPND rises each quarter to $7,313.6B → $7,496.3B → $7,580.2B → $7,583.7B. [FRED, confirmed] - 2025 (FY2025 actual): Outlays $7.01T, up $275B (4%)/$228B (3% ex-timing) YoY vs FY2024; SS/Medicare/Medicaid alone up $249B (8%). [CBO, BPC, confirmed] - 2025 (DOGE trajectory): Target cut from $2T → $1T → ~$150B claimed savings; GAO later found $110B of claimed cuts unverifiable. [debtdispatch, reason.com, reported] - 2025 (rescissions): Two enacted rescissions packages total only ~$18–20B combined. [federalbudgetiq, Mullin Senate release, confirmed] - 2026-01/04: FGEXPND continues climbing to $7,679.7B (Q1 2026) and $7,763.7B (Q2 2026). [FRED, confirmed] - 2026-05 to 2026-08: News coverage shifts to deficit blowing PAST $2T for FY2026, net interest surpassing $1T annually, debt at $39.4T; no outlet reports an aggregate spending decline. [Fox Business, IBTimes, GDELT, reported] - 2026-08: "DOGE is dead" narrative articles; program largely defunct with disputed legacy savings. [SMH/Age/Brisbane Times, WTOP, reported] # Event Will FGEXPND fall at least $250B (SAAR) below its Q4 2024 level ($7,247.7B) in any quarter through Q4 2028? # Outcomes to forecast - Yes (≥$250B decrease occurs in some quarter) - No # Kalshi market anchor **Current YES price: 4.10%** (KXGOVTCUTS-28-250). 7-day change: -9.9pp; 30-day change: -10.9pp — clear downward trend. Price range over observed window: 2%–17%. Avg daily volume: 167 contracts (thin). Trend consistent with markets pricing out large DOGE/rescission-driven cuts as actual data shows spending rising. # Sub-question answers 1. **Q4 2024 FGEXPND level & recent readings** — $7,247.662B SAAR (Q4 2024). Every subsequent quarter through Q2 2026 (latest available) has been higher: $7,313.6B, $7,496.3B, $7,580.2B, $7,583.7B, $7,679.7B, $7,763.7B. [FRED] 2. **Historical base rate of $250B+ (SAAR) drops within 4 years** — Rare; essentially only the 2021–2023 COVID-stimulus unwind qualifies. Base rate ≈3.5% of reference quarters; Monte Carlo under "calm" volatility gives ~2.9% probability over 16Q, rising to ~22% only under COVID-magnitude volatility assumptions. [code_execution analysis] 3. **Composition/contractual growth** — SS/Medicare/Medicaid rose $249B (8%) in FY2025 alone; net interest is fastest-growing category, set to exceed $1T in FY2026 and double to $2.1T by 2036. These mandatory/interest components structurally push spending up, making a 3-4% nominal decline implausible absent recession or major legislated cuts. [BPC, CBO] 4. **DOGE/rescissions delivered vs CBO path** — Enacted rescissions ~$18-20B; DOGE claimed savings collapsed from $2T target to ~$150B claimed, with GAO unable to verify $110B of it. CBO baseline projects outlays rising from $7.01T (FY2025) to ~$8.02T (FY2028) — a ~$1T increase, not a $250B decrease. [CBO, JEC, debtdispatch, reason.com] 5. **Mechanical one-quarter swing risk** — Research did not identify a specific near-term mechanical event (shutdown, sequester, large accounting reversal) large enough to swing a single quarter by $250B; FY2026 YTD outlays briefly ran ~4.4% below FY2025 YTD due to timing shifts, but this hasn't translated into a quarterly SAAR level below the Q4 2024 threshold, and full-year CBO baseline still projects growth. [claude_news; gap remains — no explicit shutdown/sequester analysis found] 6. **Kalshi pricing on this and adjacent thresholds** — Only the $250B tier data was returned (4.10%); adjacent tiers ($100B, $500B) were not retrieved in this research pass (gap). # Key facts (high-confidence, factual) 1. [FRED] FGEXPND Q4 2024 = $7,247.662B; latest (Q2 2026) = $7,763.706B — up $516B, not down. 2. [CBO/BPC] FY2025 outlays rose $275B (4%) YoY; mandatory health/retirement programs drove $249B of that alone. 3. [CBO/JEC] CBO baseline: outlays $7.01T (FY25) → $7.29T (FY26) → $7.62T (FY27) → $8.02T (FY28). 4. [debtdispatch/reason.com] DOGE savings claims collapsed from $2T target to ~$150B claimed, with $110B unverifiable per GAO. 5. [federalbudgetiq/Mullin] Enacted rescissions total only ~$18-20B combined. 6. [Kalshi] YES price 4.10%, down ~11pp in 30 days. # Cross-market signals - Kalshi related: Same series (KXGOVTCUTS-28) had 16 no-signal/unlisted tiers; adjacent-tier pricing not captured this run. - Polymarket: No matching markets found (0/100 scanned). - Sportsbook implied: N/A (not applicable to this event type). # Analyst opinions and speculation - Debt/deficit commentary (Daily Caller, IBTimes, Fox Business) uniformly frames trajectory as deteriorating ($2T+ deficits, rising interest costs), not toward spending declines. - "DOGE is dead" narrative (SMH, Age, Brisbane Times, WTOP) suggests political/organizational unwind of the main cutting initiative by mid-2026. - Legal/structural constraint: rescissions/impoundment actions contested in court; Congress retains power of the purse, limiting unilateral executive cuts (debtdispatch). # Directional lean per outcome - **Yes**: Weak support — only plausible via a severe recession, major bipartisan legislated cuts, or a one-off accounting/timing anomaly; no current catalyst identified; Monte Carlo base case ~3-5%. - **No**: Strong support — actual FGEXPND has risen every quarter since baseline; CBO baseline projects continued growth to FY2028; DOGE/rescissions savings are two orders of magnitude short of $250B; mandatory/interest spending structurally rising. Kalshi price (4.1%, declining) aligns with this. # Gaps / unknowns - No explicit analysis of shutdown/sequester/accounting-swing scenarios that could mechanically produce a one-quarter $250B dip. - Adjacent Kalshi tier prices ($100B, $500B) not retrieved — would help gauge market's full distributional view. - No Q3/Q4 2026 through 2028 FGEXPND data yet (only through Q2 2026) — future recession risk not explicitly modeled. # Calibration anchors - Kalshi current YES price: 4.10% (declining trend) — primary anchor. - Historical precedent: only COVID-19 stimulus unwind (2021-2023) produced a comparable $250B+ SAAR quarterly decline in the post-war era; no non-recessionary precedent exists.

1. Both forecasts converge tightly (3.0% and 4.0%) near the Kalshi anchor but neither explores the "widening gap" implication fully: since baseline is now $516B above threshold and rising, the required swing has grown to ~$766-770B, which is nearly a full COVID-unwind magnitude — arguably the true probability should be pushed well below the historical 3.5% base rate (which was computed from a smaller required gap), not just "shaded slightly." 2. Neither forecaster addresses the recession scenario with any specificity — given ~2028 is 2-3 years out, a business-cycle downturn is not negligible over that horizon, yet both treat "severe recession" as a throwaway tail risk without quantifying recession probability by 2028 or its typical spending impact (recessions usually increase spending via automatic stabilizers, not decrease it, which actually argues for revising the tail allowance downward, not treating recession as a Yes-supporting scenario). 3. The brief flags an unresolved gap on shutdown/sequester/accounting-swing mechanics that could mechanically cause a one-quarter dip — both forecasters mention "accounting anomaly" as a residual but don't examine that FGEXPND is a national-accounts SAAR series relatively insulated from shutdown timing noise (unlike Treasury cash outlays), which should further reduce this tail's weight rather than treating it as meaningful probability mass. 4. Both forecasts ignore the adjacent Kalshi tier gap noted in the brief (100B/500B tiers not retrieved) — cross-checking those would help validate whether 4% is well-calibrated relative to the market's broader distributional view, and neither forecaster flags this as a missed diagnostic check. 5. Forecaster 1 claims to "shade slightly below" Kalshi's 4.1% to land at 3.0%, a larger-than-stated adjustment (1.1pp, ~27% relative move) that isn't fully justified by the stated reasoning; Forecaster 2 stays essentially at the market price (4.0% vs 4.1%) with less independent analytical justification for deviating at all, revealing inconsistency in how much weight each places on their own analysis vs. the anchor despite citing nearly identical evidence. 6. Neither forecaster explicitly reconciles the declining Kalshi trend (down 10-11pp in 30 days) with their static point estimate — if the market is still trending down and forecasters expect the gap to keep widening as FGEXPND continues rising through 2028, a lower terminal estimate (e.g., sub-3%) may be more consistent with the trajectory than anchoring near current price.

2% (80% confidence)

Yes: 2% No: 98%

FGEXPND has risen every quarter since the Q4 2024 baseline, reaching $7,763.7B in Q2 2026 — $516B above baseline — so the required move to the $6,997.7B threshold is now roughly $770B, near full COVID-unwind magnitude with no comparable non-recessionary precedent. CBO's baseline projects outlays climbing to ~$8.02T by FY2028 on mandatory health/retirement growth and net interest exceeding $1T, while DOGE savings collapsed to ~$150B claimed (largely unverifiable) and enacted rescissions total only ~$18-20B. The critique is persuasive that both forecasters over-credited tail scenarios: recessions typically raise federal spending via automatic stabilizers (arguing against Yes), and FGEXPND is a national-accounts SAAR series relatively insulated from shutdown/timing cash-flow noise. Kalshi's 4.1% is thin-volume and still declining ~11pp per month, consistent with a fair value below the current quote. I therefore move modestly below both forecasts and the anchor to 2%, retaining a small allowance for an extreme legislated-cut or accounting shock over the remaining 10 quarters.

Total pipeline time: 167.2s